Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

Share Price is delayed by 15 minutes
Get Live Data
12.60    -0.05 (-0.40%)
Bid:
12.60
Ask:
12.95
Spread: 0.35 (2.778%)
Market Cap: £42.85m
BVC Live PriceLast checked at - London Stock Exchange

Intraday Batm Advanced Share Chart

Directorate Changes

6 Oct 2022 07:00

RNS Number : 9495B
BATM Advanced Communications Ld
06 October 2022
 

LEI: 213800FLQUB9J289RU66

6 October 2022

 

BATM Advanced Communications Limited

("BATM" or "the Group")

 

Directorate Changes

 

The Board of BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, is pleased to announce that Moti Nagar, the Group's Chief Financial Officer, is to be promoted to become its Chief Executive Officer effective from 1 January 2023. Zvi Marom, its current Chief Executive Officer, is to step down on 1 January 2023, but will remain on the Board as Non-Executive Director.

 

Mr. Nagar has been the Group's Chief Financial Officer since 1 January 2015 having joined BATM in June 2014 as VP Finance. Over the past three years, in addition to being the CFO, Mr. Nagar has been the de facto Chief Operating Officer of the Group, supporting Dr. Marom in the running of day-to-day operations. Prior to BATM, Mr. Nagar held several senior positions at Deloitte from 2005, including as a Senior Manager from 2011-2014. During that time, Mr. Nagar had various responsibilities, including handling the accounts of leading corporate clients in Israel and overseas, with companies traded on the LSE, NASDAQ and TASE, as well as private businesses operating in a range of sectors.

 

Dr. Gideon Chitayat, Chairman of Board, said: "On behalf of the Board, I would like to thank Zvi for his tireless commitment and outstanding contribution to the development and success of BATM since founding it in 1992. Under his leadership, the team at BATM has delivered exceptional value creation for shareholders during those years. He passes on BATM in a strong financial position and with a solid platform to push ahead with the commercialisation of the IP developed within the Group. We look forward to benefitting from his continued contribution as a Board member.

 

"It is a measure of our reputation as a business that we are able to attract and retain high-quality people and I am delighted that Moti has agreed to become our Chief Executive Officer. Moti brings his sound financial knowledge to this position and, coupled with his capital markets and M&A expertise, I am sure he will help shape the future of BATM as a global company. Most importantly, having helped in running the day-to-day operations over the past three years, he not only provides continuity but has impressed the Board with exciting ideas on how to take the Group to the next level. We look forward to working with him in this new role and leveraging his extensive experience."  

 

Dr. Zvi Marom, Chief Executive Officer of BATM, commented: "It has been a privilege to serve as Chief Executive Officer of BATM. Since I founded the business 30 years ago, I have truly enjoyed working with our incredible teams and I would like to take this opportunity to thank my colleagues with whom I have had the pleasure of working and who have provided so much inspiration. I am incredibly proud of what we have achieved together.

 

"With both the Networking & Cyber and Bio-medical divisions at key inflection points, I feel now is the natural moment for me to hand over the running of the Group to someone who can progress it to the next stage. It gives me great confidence to welcome Moti as my successor. Moti has the necessary pedigree and is highly respected by the people in the Group and our shareholders. He has my full support as the right person to take BATM forward on the next leg of its exciting journey. In my new role, I will make myself available to ensure smooth transition and help wherever I can to enable BATM to go from strength to strength."

 

Moti Nagar, Incoming Chief Executive Officer of BATM, said: "I am delighted to take on the role of Chief Executive Officer of BATM. Under the leadership of Zvi, the remarkable progress over the past few years has created a strong platform for future growth. I look forward to working closely with the Board, the BATM team and our key partners as we continue to drive forward a multi-pronged growth strategy and realise further value for shareholders."

 

 

Enquiries:

 

BATM Advanced Communications

Dr. Zvi Marom, Chief Executive Officer

+972 9866 2525

Moti Nagar, Chief Financial Officer

 

Shore Capital

Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory)

Henry Willcocks (Corporate Broking)

+44 20 7408 4050 

 

Gracechurch Group

Harry Chathli, Claire Norbury

+44 20 4582 3500

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADZMGGRKLGZZM
Date   Source Headline
26th May 20267:00 amRNSBlock Listing Interim Review
21st Apr 20267:00 amRNSPublication of Annual Report
11th Mar 20267:00 amRNSFull Year Results
3rd Mar 202612:00 pmRNSHolding(s) in Company
10th Feb 20267:00 amRNSSale of Non-core Business
3rd Feb 20267:00 amRNSHolding(s) in Company
2nd Feb 20267:00 amRNSHolding(s) in Company
19th Jan 20267:00 amRNS-RBATM selected as FPT Israel cybersecurity partner
12th Jan 20267:00 amRNSHolding(s) in Company
12th Jan 20267:00 amRNSHolding(s) in Company
8th Jan 202611:00 amRNSTransaction in own shares and Total Voting Rights
2nd Jan 20267:01 amRNSDirector Declaration
2nd Jan 20267:01 amRNSDirector Declaration
2nd Jan 20267:00 amRNSCompletion of Sale of Diagnostics Distributor
2nd Jan 20267:00 amRNSCompletion of Sale of Diagnostics Distributor
29th Dec 20257:00 amRNSAppointment of Chairman and Directorate Change
29th Dec 20257:00 amRNSAppointment of Chairman and Directorate Change
10th Dec 202512:00 pmRNSAGM Result, Directorate Change & AMS Sale Update
1st Dec 20257:00 amRNSTotal Voting Rights
25th Nov 20257:00 amRNSBlock Listing Interim Review
17th Nov 20257:00 amRNSNew Carrier Ethernet Order
5th Nov 20257:00 amRNSNotice of AGM and Directorate Changes
6th Oct 20257:00 amRNSSale of Diagnostics Distributor
26th Sep 20257:00 amRNSDirectorate Change
18th Aug 20257:00 amRNSInterim Results
4th Aug 20257:00 amRNSTotal Voting Rights
24th Jul 20257:00 amRNSSale of Non-Core Businesses and Notice of Results
23rd Jun 20257:00 amRNSDirectorate Change
27th May 20257:00 amRNSBlock Listing Interim Review
12th May 20257:00 amRNSOrder for ultra-high speed encryption development
6th May 20257:00 amRNS-RBATM unveils new brand identity
8th Apr 202511:00 amRNSAnnual Report Publication and AGM Update Statement
27th Mar 20257:00 amRNSNew strategic customer for Edgility in Brazil
17th Mar 20257:00 amRNSFull Year Results
5th Mar 20257:00 amRNSUpdate on Strategy and Trading
24th Feb 20257:00 amRNSHolding(s) in Company
16th Jan 20257:00 amRNSADOR appoints Nadhim Zahawi to lead Advisory Board
19th Dec 20243:30 pmRNSResult of AGM and Director Appointment
19th Dec 20247:00 amRNSNew Tier 1 Customer for Edgility in Mexico
11th Dec 20247:00 amRNSNATlab commences pre-clinical validation
3rd Dec 20247:00 amRNSBlock Listing Interim Review
2nd Dec 20247:00 amRNSBATM receives orders of $2.4m for Edgility
25th Nov 20247:00 amRNSBlock listing Interim Review
14th Nov 202411:00 amRNSNotice of AGM and Proposed Director Appointment
4th Nov 20247:00 amRNSTotal Voting Rights
19th Aug 20247:00 amRNSInterim Results
10th Jul 20247:00 amRNSAmazon Web Services partnership for Edgility
2nd Jul 20247:00 amRNSCommercial markets cybersecurity partnership
3rd Jun 20247:00 amRNSBlock Listing Interim Review
28th May 20247:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.